Scott Schlackman Purchases 2,500 Shares of Medifast (NYSE:MED) Stock

Medifast Inc (NYSE:MED) Director Scott Schlackman acquired 2,500 shares of the stock in a transaction on Monday, May 11th. The stock was bought at an average price of $12.53 per share, for a total transaction of $31,325.00. Following the transaction, the director owned 30,549 shares in the company, valued at approximately $382,778.97. This represents a 8.91% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.

Scott Schlackman also recently made the following trade(s):

• On Friday, May 8th, Scott Schlackman purchased 2,500 shares of Medifast stock. The shares were purchased at an average cost of $12.65 per share, for a total transaction of $31,625.00.

Medifast Stock Performance

NYSE MED traded up $0.16 during mid-day trading on Tuesday, reaching $12.56. 168,560 shares of the stock were exchanged, compared to its average volume of 210,108. Medifast Inc has a 1 year low of $9.22 and a 1 year high of $15.46. The business’s 50 day moving average is $10.66 and its 200-day moving average is $11.09. The company has a market capitalization of $139.63 million, a P/E ratio of -6.86 and a beta of 0.55.

Medifast (NYSE:MED) last announced its quarterly earnings results on Monday, May 4th. The specialty retailer reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.36. The firm had revenue of $76.04 million during the quarter, compared to analyst estimates of $69.20 million. Medifast had a negative return on equity of 4.80% and a negative net margin of 5.78%.Medifast has set its FY 2026 guidance at -2.750–1.550 EPS and its Q2 2026 guidance at -1.000–0.500 EPS. Equities analysts predict that Medifast Inc will post -2 earnings per share for the current fiscal year.

Institutional Trading of Medifast

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Dimensional Fund Advisors LP boosted its holdings in shares of Medifast by 10.9% in the first quarter. Dimensional Fund Advisors LP now owns 361,762 shares of the specialty retailer’s stock valued at $3,686,000 after acquiring an additional 35,522 shares in the last quarter. Corient Private Wealth LLC acquired a new position in shares of Medifast during the 4th quarter worth $139,000. Empowered Funds LLC grew its stake in shares of Medifast by 11.1% during the 4th quarter. Empowered Funds LLC now owns 44,773 shares of the specialty retailer’s stock worth $478,000 after purchasing an additional 4,462 shares during the period. Man Group plc grew its stake in shares of Medifast by 10.8% during the 4th quarter. Man Group plc now owns 236,500 shares of the specialty retailer’s stock worth $2,526,000 after purchasing an additional 23,070 shares during the period. Finally, Trexquant Investment LP grew its stake in shares of Medifast by 88.0% during the 4th quarter. Trexquant Investment LP now owns 126,959 shares of the specialty retailer’s stock worth $1,356,000 after purchasing an additional 59,439 shares during the period. Hedge funds and other institutional investors own 95.51% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on MED. Weiss Ratings lowered shares of Medifast from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 6th. Stephens lowered their price objective on shares of Medifast from $15.00 to $12.00 and set an “equal weight” rating for the company in a research note on Thursday, February 19th. Finally, Wall Street Zen upgraded shares of Medifast from a “sell” rating to a “hold” rating in a research note on Saturday, March 21st. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Medifast presently has a consensus rating of “Reduce” and an average price target of $12.00.

About Medifast

Medifast, Inc (NYSE: MED) is a health and wellness company specializing in clinically supported weight-loss, weight-management and healthy living products and services. Through its OPTAVIA brand, the company offers a range of meal replacement products, snacks, supplements and coaching programs designed to support metabolic health and sustainable lifestyle changes. Medifast markets its products directly to consumers via a network of independent distributors—known as OPTAVIA Coaches—who provide personalized guidance and support throughout the client’s weight‐loss journey.

Founded in 1980 by William Vitale and headquartered in Baltimore, Maryland, Medifast has grown into a nationally recognized provider of nutrition and weight‐management solutions.